Compare Humana Inc (HUM) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Rocket Lab USA Inc — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Rocket Lab USA Inc trades at $69.65 (market cap $45.99B). The key difference: Humana Inc and Rocket Lab USA Inc are close in size by market cap, and Humana Inc pays a 0.89% dividend while Rocket Lab USA Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Rocket Lab USA Inc for 29 Days on average.
| HUM | RKLB | |
|---|---|---|
Market Cap | $47.61B | $45.99B |
Volume | 1,827,332 | 20,411,657 |
Sector | Health | Industrials |
52-Week High | $409.85 | $150.23 |
52-Week Low | $163.67 | $39.48 |
Typical Hold Time | 53 Days | 29 Days |
Enterprise Value | $54.97B | $43.82B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Rocket Lab (RKLB) trades at $71.92, down 4.18% today, amid a neutral technical outlook with mixed moving averages and oscillators. Fundamentally, the company shows strong revenue growth, with 2026 revenue projected at $769 million, but remains unprofitable with a net loss of $165 million. Recent positive sentiment is driven by securing its largest-ever commercial Electron launch deal, a 20-mission contract with Synspective that expands its backlog past 100 missions, as reported by The Motley Fool on October 3, 2026.
The investment outlook is cautiously optimistic, supported by a strong analyst consensus with a $109.20 price target and 76% buy ratings. Key opportunities include backlog growth and Neutron rocket development, while risks involve sustained losses, high valuation multiples, and competitive pressure from SpaceX. Profitability remains the critical hurdle for justifying its premium valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
